Month: May 2023

Boussard & Gavaudan Investment Management LLP: Form 8.3 – Network International Holdings

Written by Customer Service on May 11, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Gestion SAS acting on behalf of various funds(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Network International Holdings PLC(d) If an exempt fund manager connected...

United-Guardian Reports First Quarter Financial Results

Written by Customer Service on May 11, 2023. Posted in Earnings Releases And Operating Results.

HAUPPAUGE, N.Y., May 11, 2023 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) today announced financial results for the first quarter of fiscal year 2023, which ended on March 31, 2023. Net sales decreased 34% compared to the prior year’s first quarter, decreasing from $3,892,358 to $2,570,324. Net income for the quarter decreased by 17% from $911,465 ($0.20 per share) in 2022 to $756,081 ($0.16 per share) this year. Beatriz Blanco, President of United-Guardian, stated, “The first quarter results reflect the world’s current stagnating and challenging economic environment. The sales decrease was primarily attributable to a decrease in sales of the Company’s cosmetic ingredients and medical lubricants, which was partially offset by an increase in sales of the Company’s pharmaceutical and industrial products. Our main distributor...

[INVNT GROUP]™ achieves record global growth, accelerating history-making brand campaigns, strategic partnerships, and humanitarian work.

Written by Customer Service on May 11, 2023. Posted in Earnings Releases And Operating Results.

[INVNT GROUP] The Global BrandStory Project The leading agency portfolio of complementary global brand storytelling disciplines, continues its explosive growth trajectory and worldwide expansion, reporting a top line revenue of $142 Million in 2022, up over 132% year-over-year (YOY).New York, NY, May 11, 2023 (GLOBE NEWSWIRE) — [INVNT GROUP] THE GLOBAL BRANDSTORY PROJECT™ and leading agency portfolio of complementary brand storytelling disciplines, continues its explosive growth trajectory and worldwide expansion, reporting a top line revenue of $142 Million in 2022, up over 132% year-over-year (YOY). Led by Scott Cullather, President & CEO of [INVNT GROUP] and CEO of INVNT.ATOM, the group represents a growing portfolio of innovative complementary disciplines designed to help forward-thinking brands everywhere,...

Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023

Written by Customer Service on May 11, 2023. Posted in Public Companies.

BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r B-ALL population NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced the release of an abstract, which was accepted for presentation at the European Hematology Association (EHA) Hybrid Congress, taking place on June 8-15, 2023 in Frankfurt, Germany. Cellectis will present, in a poster session, updated clinical and translational data on its BALLI-01 clinical trial (evaluating UCART22) in patients with relapsed/refractory B-cell acute lymphoblastic Leukemia (r/r B-ALL). “Cellectis is excited to present updated...

Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress

Written by Customer Service on May 11, 2023. Posted in Public Companies.

WATERTOWN, Mass., May 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced upcoming clinical data to be presented at the European Hematology Association (EHA) 2023 Congress in Frankfurt, Germany. The presentation will report initial results from BEACON, the Phase 2, randomized, open‐label, parallel arm trial of bitopertin in Erythropoietic Protoporphyria (EPP) that is ongoing in Australia. This study was designed to assess changes in levels of protoporphyrin IX (PPIX), the toxic metabolite that causes disease pathology in EPP, as well as measures of photosensitivity, quality of life, and safety and tolerability. Additionally,...

TOWER ONE WIRELESS ANNOUNCES ELEVEN TOWERS COMPLETED – ADDITIONAL NON-CANCELLABLE RENT OF $ 1,200,000

Written by Customer Service on May 11, 2023. Posted in Public Companies.

TOWER ONE CONSTRUCTION UPDATE FOR THE MONTH OF APRIL 2023 VANCOUVER, BC, CANADA, May 11, 2023 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) is pleased to provide a construction update for the month of April 2023. During the month of April, the Company completed eleven (11) new towers: one (1) tower in Ecuador, and ten (10) towers in Colombia with a total of fifty-nine (59) towers under construction in these specific countries, as well. These towers are built to suit specific clients and will provide a total, non-cancellable rent revenue for 10 years of approximately $1,200,000 (*This figure excludes colocation revenue upside and inflation escalator terms).Tower PorfolioTotal Towers Built Month 11Total Towers Built YTD 49Total Towers in Portfolio 397Colocations...

Coloplast B.V. – Announcement no. 03/2023 – Interim Financial Report H1 2022/23

Written by Customer Service on May 11, 2023. Posted in Earnings Releases And Operating Results.

H1 2022/23 Interim financial results, H1 2022/23 1 October 2022 – 31 March 2023 Coloplast delivered Q2 organic growth of 8% and 28% EBIT margin1). Reported revenue in DKK was up by 10%.Organic growth rates by business area: Ostomy Care 6%, Continence Care 6%, Voice and Respiratory Care 9% (2 months), Wound and Skin Care 13% (Wound Care 12%), and Interventional Urology 17%. Solid Q2 for Chronic Care with continued good momentum across regions ex. China, which detracted from growth in Ostomy Care due to COVID-19. Towards the end of Q2, hospital access in China significantly improved, positively impacting procedural volumes. Growth in Continence Care continued to be impacted by backorders in Collecting Devices. Voice and Respiratory Care growth was driven by solid momentum in both the laryngectomy and tracheostomy businesses. Strong...

Form 8.3 – [EMIS Group plc – 10 05 2023] – (CGWL)

Written by Customer Service on May 11, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Orkuveita Reykjavíkur – Green Bond Auction May 16

Written by Customer Service on May 11, 2023. Posted in Public Companies.

Reykjavík Energy (Orkuveita Reykjavíkur; OR) is holding a bond auction Tuesday, May 16, 2023. The green bond classes OR020934 GB and OR180255 GB will be offered for sale. OR020934 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of September 2, 2034. Previously, bonds with a nominal value of ISK 14,577 million have been issued in the class. OR0180255 GB bears fixed indexed interest and pays equal payments every six months with a final maturity date of February 18, 2055. Previously, bonds with a nominal value of ISK 23,221 million have been issued in the class. Fossar Investment Bank hf. oversees the issuance and sale of the bonds as well as their admission to trading on the Nasdaq sustainable bonds market in Iceland. Bids must be submitted to the email address utbod@fossar.is before 17:00...

Mangoceuticals Launches New “Some Things Are Better Hard” Viral Video Ad Campaign

Written by Customer Service on May 11, 2023. Posted in Public Companies.

DALLAS, TX, May 11, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is excited to announce the launch of its “Some Things Are Better Hard” digital marketing campaign (the “Campaign”). The Campaign leverages a new beautifully produced full-length video comprised of four individual video shorts, which will be widely distributed, together as a whole and separately, across multiple social media platforms, including, but not limited to, Facebook, Instagram, Snapchat, TikTok, YouTube, Google, and Twitter. The composition is designed to...

Month: May 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals